Executive Education: Pharmaceuticals and the Law

16 – 18 September 2024

Hybrid course, offered in person at the BIICL office in London and virtually.

Announcing a new executive education programme from The British Institute of International and Comparative Law (BIICL) and the Centre for Commercial law Studies (CCLS) at Queen Mary University of London (QMUL) on Pharmaceuticals and the Law.

BIICL is a world leading research organisation in international, comparative and rule of law issues, providing research-informed training with an applied perspective. The CCLS is a global leader in research, teaching and professional training in commercial law.

Building on the combined expertise of the two institutions, this executive education programme offers diverse legal and interdisciplinary perspectives exploring the nexus between global public health, intellectual property, regulation, liability and human rights issues.

The programme will be of particular interest to legal practitioners; executives of pharmaceutical and related companies including compliance officers; civil servants; those working for international organisations and for NGOs and anyone else with a keen interest in the link between public health, intellectual property and regulation.

Course topics

Pharma – Regulation, Liability and Broader Responsibilities:

• Global Health Law – Implications for Pharmaceutical Companies
• Pharma, Intellectual Property and International Trade Law
• Access to medicines: from HIV/AIDS to Covid-19
• Product Liability and pharma
• Comparative approaches to pharmaceutical regulation
• Business and human rights and the Pharma Industry

Pharma and Intellectual Property:

• Overview of the pharmaceutical industry and national systems of innovation
• Pharmaceutical intellectual property and product regulation
• The pharmaceutical industry and the life sciences revolution from 1980: Major science and technology development affecting the pharmaceutical business and Implications for intellectual property
• Personalised and precision medicine; digital medicine
• What does the pharmaceutical industry patent?
• Alternative pharmaceutical innovation models

Course Tutors

Professor Uma Suthersanen, Queen Mary University of London

Professor Graham Dutfield, University of Leeds

Professor Duncan Fairgrieve, BIICL

Dr. Irene Pietropaoli, BIICL

Pricing and Registration

The course cost is £1200 per person.